CGL
Clarius Group LLC Portfolio holdings
AUM
$1.72B
This Quarter Return
+17.07%
1 Year Return
+14.66%
3 Year Return
+85.31%
5 Year Return
+125.74%
10 Year Return
–
AUM
$411M
AUM Growth
+$411M
(+49%)
Cap. Flow
+$91.1M
Cap. Flow
% of AUM
22.16%
Top 10 Holdings %
Top 10 Hldgs %
59.59%
Holding
216
New
98
Increased
81
Reduced
10
Closed
8
Top Buys
| 1 |
Microsoft
MSFT
|
$39.5M |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
$4.33M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$3.82M |
| 4 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
$3.35M |
| 5 |
Amazon
AMZN
|
$1.96M |
Top Sells
| 1 |
SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
$8.85M |
| 2 |
iShares Core Conservative Allocation ETF
AOK
|
$7.5M |
| 3 |
AVLR
Avalara, Inc.
AVLR
|
$2.51M |
| 4 |
APTI
Apptio, Inc. Class A Common Stock
APTI
|
$2.48M |
| 5 |
ESL
Esterline Technologies
ESL
|
$1.27M |
Sector Composition
| 1 | Industrials | 23.48% |
| 2 | Technology | 19.23% |
| 3 | Consumer Discretionary | 12.51% |
| 4 | Financials | 4.85% |
| 5 | Communication Services | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bristol-Myers Squibb
BMY
$96B
| $342K | 0.08% |
7,171
+3,310
| +86% | +$158K |
|
127
Elevance Health
ELV
$71.8B
| $341K | 0.08% |
+1,188
| New | +$341K |
|
128
Stryker
SYK
$150B
| $341K | 0.08% |
+1,728
| New | +$341K |
|
129
CSX Corp
CSX
$60.6B
| $337K | 0.08% |
+4,506
| New | +$337K |
|
130
Gilead Sciences
GILD
$140B
| $334K | 0.08% |
5,136
+1,703
| +50% | +$111K |
|
|
CELG
131
DELISTED
Celgene Corp
CELG
| $332K | 0.08% |
+3,522
| New | +$332K |
|
132
Charter Communications
CHTR
$36.3B
| $331K | 0.08% |
+956
| New | +$331K |
|
133
FedEx
FDX
$54.5B
| $326K | 0.08% |
+1,794
| New | +$326K |
|
134
Qualcomm
QCOM
$173B
| $315K | 0.08% |
+5,519
| New | +$315K |
|
135
Ross Stores
ROST
$48.1B
| $313K | 0.08% |
3,357
+703
| +26% | +$65.5K |
|
136
Aon
AON
$79.1B
| $308K | 0.07% |
+1,803
| New | +$308K |
|
137
iShares Morningstar Mid-Cap ETF
IMCB
$1.18B
| $308K | 0.07% |
1,640
| – | – |
|
138
Colgate-Palmolive
CL
$67.9B
| $306K | 0.07% |
+4,458
| New | +$306K |
|
139
Vanguard Real Estate ETF
VNQ
$34.6B
| $303K | 0.07% |
3,482
-1,896
| -35% | -$165K |
|
140
Boston Scientific
BSX
$156B
| $302K | 0.07% |
+7,869
| New | +$302K |
|
141
Intuit
INTU
$186B
| $302K | 0.07% |
+1,156
| New | +$302K |
|
142
Charles Schwab
SCHW
$174B
| $300K | 0.07% |
+7,023
| New | +$300K |
|
143
General Motors
GM
$55.8B
| $299K | 0.07% |
+8,067
| New | +$299K |
|
144
Deere & Co
DE
$129B
| $298K | 0.07% |
+1,867
| New | +$298K |
|
145
Bank of New York Mellon
BK
$74.5B
| $296K | 0.07% |
+5,877
| New | +$296K |
|
146
iShares Global Tech ETF
IXN
$5.71B
| $291K | 0.07% |
1,700
| – | – |
|
147
Ecolab
ECL
$78.6B
| $290K | 0.07% |
+1,641
| New | +$290K |
|
148
Expeditors International
EXPD
$16.4B
| $288K | 0.07% |
3,797
+114
| +3% | +$8.65K |
|
149
Marsh & McLennan
MMC
$101B
| $284K | 0.07% |
+3,024
| New | +$284K |
|
150
Zoetis
ZTS
$69.3B
| $281K | 0.07% |
+2,788
| New | +$281K |
|